What does the IPERIONX (IPX) Form 3 filing show about the CEO’s share ownership?

The Form 3 shows CEO Anastasios Arima directly holds 11,739,782 Ordinary Shares of IPERIONX Ltd. It also discloses significant equity incentives, including restricted stock units and performance rights linked to future share issuance and performance milestones.

IPERIONX (IPX) CEO reports 11.7M shares plus RSUs and performance rights

Q: How many IPERIONX (IPX) Restricted Stock Units does the CEO hold and when do they vest?

The CEO holds 738,576 Restricted Stock Units . Footnotes state that 318,666 RSUs vest in December 2026 and 419,910 RSUs vest in April 2028 , outlining a multi-year equity compensation schedule tied to continued service and performance.

Q: Are there any buy or sell transactions in this IPERIONX (IPX) Form 3 for the CEO?

No buy or sell transactions are reported. The Form 3 is an initial ownership filing listing the CEO’s existing Ordinary Shares, Restricted Stock Units, and performance rights, without recording new purchases, sales, or option exercises on the reported date.

Q: On which exchange are IPERIONX (IPX) Ordinary Shares referenced in the Form 3 traded?

A footnote states that IPERIONX Ordinary Shares are traded on the Australian Securities Exchange (ASX) . The filing uses this context while detailing the CEO’s direct holdings and derivative-style performance rights over IPX Ordinary Shares.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

IPERIONX Ltd Chief Executive Officer Anastasios Arima reports his existing equity stake in the company. He directly holds 11,739,782 Ordinary Shares, which trade on the Australian Securities Exchange. He also holds 738,576 Restricted Stock Units, with portions vesting in December 2026 and April 2028.

In addition, Arima holds three tranches of performance rights over IPX Ordinary Shares, each covering 435,806 underlying shares with exercise prices of A$6, A$7, and A$8. These performance rights are exercisable from April 2029 and expire in April 2030, providing potential future share issuance tied to performance conditions.

Insider Trade Summary

5 transactions reported

Mixed 5 txns

Insider Arima Anastasios

Role Chief Executive Officer

Type	Security	Shares	Price	Value
holding	Performance Rights (A$6)	--	--	--
holding	Performance Rights (A$7)	--	--	--
holding	Performance Rights (A$8)	--	--	--
holding	Ordinary Shares	--	--	--
holding	Restricted Stock Units	--	--	--

Holdings After Transaction: Performance Rights (A$6) — 435,806 shares (Direct); Performance Rights (A$7) — 435,806 shares (Direct); Performance Rights (A$8) — 435,806 shares (Direct); Ordinary Shares — 11,739,782 shares (Direct); Restricted Stock Units — 738,576 shares (Direct)

Footnotes (1)

Ordinary Shares are traded on the Australian Stock Exchange. (ASX) 318,666 vest in December 2026; 419,910 vest in April 2028 Six Australian Dollars Seven Australian Dollars Eight Australian Dollars

Understanding Insider Trading Forms →

03/19/2026 - 09:23 PM

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Arima Anastasios

(Last)

(First)

(Middle)

1092 CONFROY DRIVE

(Street)

SOUTH BOSTON

VIRGINIA

24592

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/19/2026

3. Issuer Name and Ticker or Trading Symbol
IPERIONX Ltd [ IPX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Executive Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares⁽¹⁾	11,739,782	D
Restricted Stock Units	738,576⁽²⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Performance Rights (A$6)	04/10/2029	04/10/2030	IPX Ordinary Shares	435,806	$6⁽³⁾	D
Performance Rights (A$7)	04/10/2029	04/10/2030	IPX Ordinary Shares	435,806	$7⁽⁴⁾	D
Performance Rights (A$8)	04/10/2029	04/10/2030	IPX Ordinary Shares	435,806	$8⁽⁵⁾	D

Explanation of Responses:

1. Ordinary Shares are traded on the Australian Stock Exchange. (ASX)

2. 318,666 vest in December 2026; 419,910 vest in April 2028

3. Six Australian Dollars

4. Seven Australian Dollars

5. Eight Australian Dollars

	Samantha Birdsong Manning	03/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

How many IPERIONX (IPX) Restricted Stock Units does the CEO hold and when do they vest?

The CEO holds 738,576 Restricted Stock Units. Footnotes state that 318,666 RSUs vest in December 2026 and 419,910 RSUs vest in April 2028, outlining a multi-year equity compensation schedule tied to continued service and performance.

What performance rights are reported for the IPERIONX (IPX) CEO in the Form 3?

The filing lists three performance right tranches, each over 435,806 underlying IPX Ordinary Shares, with exercise prices of A$6, A$7, and A$8. These rights are exercisable from April 2029 and expire in April 2030, subject to conditions.

Are there any buy or sell transactions in this IPERIONX (IPX) Form 3 for the CEO?

No buy or sell transactions are reported. The Form 3 is an initial ownership filing listing the CEO’s existing Ordinary Shares, Restricted Stock Units, and performance rights, without recording new purchases, sales, or option exercises on the reported date.

On which exchange are IPERIONX (IPX) Ordinary Shares referenced in the Form 3 traded?

A footnote states that IPERIONX Ordinary Shares are traded on the Australian Securities Exchange (ASX). The filing uses this context while detailing the CEO’s direct holdings and derivative-style performance rights over IPX Ordinary Shares.